Ads
related to: adult stem cells
Search results
Strategy Could Expand Stem Cell Donor Pool for People Battling Blood Cancers
WFMZ Eastern Pennsylvania and Western New Jersey· 6 days agoAn older drug used in a new way could open the path for more patients with potentially deadly blood...
A Guide to Managing Covid This Summer
New York Times· 5 hours agoHere’s what to know about symptoms, testing and treatment. KP.2, one of these variants, now accounts for 28.5 percent of cases, and data from the Centers...
Everything You Need to Know About Fetal Brain Development
Parents via Yahoo News· 4 hours agoThat means your baby is also tasting every time swallowing happens. By the end of the second...
The world’s first tooth-regrowing drug has been approved for human trials
Engadget· 4 days agoThe world’s first tooth-regrowing drug has been approved for human trials. If things go as planned,...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 49 minutes agoLongeveron (NASDAQ: LGVN) is a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions. The company today announced the launch of its contract development and
Insulin may be a thing of the past thanks to this groundbreaking diabetes cure
BGR· 4 days agoDiabetes is one of the world’s biggest health problems, an illness that doesn’t have a cure. You can...
What Happens to Your Body When You Take NAD
Verywell Fit via Yahoo News· 5 hours agoCan you boost your energy with a NAD supplement? NAD is a cellular coenzyme responsible for turning the food you eat into usable energy. Learn more about...
Autolus reports promising results for obe-cel in leukemia study By Investing.com
Investing.com· 3 days agoAutolus Therapeutics plc (NASDAQ:AUTL), a biopharmaceutical company focused on T cell therapies for...
Advances in CAR T-Cell Therapy for Multiple Myeloma
MedPage Today· 4 days agoB-cell maturation antigen (BCMA)-directed CAR T-cell therapies are now established options for treating multiple myeloma after relapse, but efforts are...
...Administration Approves Bristol Myers Squibb’s Breyanzi as a New CAR T Cell Therapy for Relapsed...
Morningstar· 4 days agoU.S. Food and Drug Administration Approves Bristol Myers Squibb’s Breyanzi as a New CAR T Cell Therapy for Relapsed or Refractory Mantle Cell Lymphoma In ...
